Table of Contents

company-logo

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance to identify carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

T2 Biosystems Dividend Announcement

• T2 Biosystems does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on T2 Biosystems dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

T2 Biosystems Dividend History

T2 Biosystems Dividend Yield

T2 Biosystems current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing T2 Biosystems stock? Use our calculator to estimate your expected dividend yield:

T2 Biosystems Financial Ratios

P/E ratio-0.20
PEG ratio0.02
P/B ratio-0.75
ROE205.97%
Payout ratio0.00%
Current ratio0.40
Quick ratio0.24
Cash Ratio0.09

T2 Biosystems Dividend FAQ

Does T2 Biosystems stock pay dividends?
T2 Biosystems does not currently pay dividends to its shareholders.
Has T2 Biosystems ever paid a dividend?
No, T2 Biosystems has no a history of paying dividends to its shareholders. T2 Biosystems is not known for its dividend payments.
Why doesn't T2 Biosystems pay dividends?
There are several potential reasons why T2 Biosystems would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will T2 Biosystems ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While T2 Biosystems has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is T2 Biosystems a dividend aristocrat?
T2 Biosystems is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is T2 Biosystems a dividend king?
T2 Biosystems is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is T2 Biosystems a dividend stock?
No, T2 Biosystems is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy T2 Biosystems stocks?
To buy T2 Biosystems you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy T2 Biosystems stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.